Related Experiment Video
Updated: May 4, 2026
10:16
Production and Targeting of Monovalent Quantum Dots
Published on: October 23, 2014
26.4K
Protein-conjugated quantum dots interface: binding kinetics and label-free lipid detection
Md Azahar Ali1, S Srivastava, M K Pandey
1Department of Science and Technology Centre on Biomolecular Electronics, Biomedical Instrumentation Section, CSIR-National Physical Laboratory , Dr. K. S. Krishnan Marg, New Delhi, Delhi 110012, India.
Analytical Chemistry
|January 15, 2014
Summary
This study introduces a novel label-free biosensor using cadmium sulfide quantum dots for detecting low-density lipoprotein (LDL). The biosensor demonstrates high sensitivity and specificity for biomolecular interaction analysis.
Area of Science:
- Nanotechnology
- Biomedical Engineering
- Analytical Chemistry
Background:
- Investigating biomolecular interactions is crucial for diagnostics and drug development.
- Label-free biosensing offers advantages in speed and simplicity over traditional methods.
- Quantum dots (QDs) provide unique optical and electronic properties for biosensing applications.
Purpose of the Study:
- To develop and validate a label-free biosensor platform for investigating antigen-antibody binding kinetics.
- To utilize L-cysteine capped cadmium sulfide (CdS) quantum dots functionalized with antibodies for detecting low-density lipoprotein (LDL).
- To evaluate the performance of the biosensor using electrochemical and surface plasmon resonance (SPR) techniques.
Main Methods:
- Fabrication of a biosensor using L-cysteine capped CdS QDs self-assembled on a gold-coated electrode.
- Covalent functionalization of the QD-modified electrode with apolipoprotein B-100 antibodies (AAB).
- Detection of LDL using electrochemical impedance spectroscopy and SPR analysis.
Main Results:
- The AAB/CysCdS/Au biosensor exhibited high sensitivity (32.8 kΩ μM(-1)/cm(2)) for LDL detection within the 5-120 mg/dL range.
- SPR analysis revealed a highly specific interaction with LDL, showing an association constant of 33.4 kM(-1) s(-1) and a dissociation constant of 0.896 ms(-1).
- The platform demonstrated high affinity and specificity for LDL biomolecules.
Conclusions:
- The developed CysCdS-Au platform is an effective label-free biosensing device.
- The biosensor enables efficient investigation of biomolecular interactions, specifically antigen-antibody kinetics.
- This technology holds promise for high-throughput, compact biosensing applications.
